SCHEMBL23722848

SCHEMBL23722848

CCN(CC)CCNC(=O)c1cc(-c2ccccc2)nc2ccc(Cl)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.60
CA1 P00915 2/20 0.60
CA2 P00918 2/20 0.60
CA9 Q16790 2/20 0.60
KDM4E B2RXH2 7/20 0.58
ALDH1A1 P00352 6/20 0.58
TP53 P04637 3/20 0.58
RAD52 P43351 2/20 0.58
GAA P10253 2/20 0.58
MAPT P10636 2/20 0.58
NPC1 O15118 1/20 0.58
RXFP1 Q9HBX9 1/20 0.58
RAB9A P51151 1/20 0.58
UBE2I P63279 1/20 0.58
CACNA1B Q00975 1/20 0.58
APBA1 Q02410 1/20 0.58
SAE1 Q9UBE0 1/20 0.58
UBA2 Q9UBT2 1/20 0.58
UBE2N P61088 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23722836 0.89 MOK (0.64) CA12CA1CA2CA9KDM4E
SCHEMBL23722876 0.88 KDM4E (0.72) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722867 0.88 ALDH1A1 (0.58) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722863 0.86 KDM4E (0.70) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722845 0.86 TACR3 (0.63) CA12CA1CA2CA9KDM4E
SCHEMBL23722843 0.82 RAD52 (0.81) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722895 0.82 TP53 (0.66) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722850 0.80 MAPT (0.66) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL16099320 0.78 HTT (0.61) CA12CA1CA2CA9KDM4E
SCHEMBL23722839 0.78 ALDH1A1 (0.67) KDM4EALDH1A1TP53RAD52GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF AR, KLK3, BRDT CA12 1274/4885CA1 2135/4885CA2 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.